What is Newark Trade?
Newark Trade operates as a sophisticated provider of comprehensive printing solutions, bridging the gap between creative design and industrial-scale production. The firm specializes in a diverse array of services, including digital, offset, and large-format display printing, which are essential for clients aiming to maximize their market presence. A core differentiator for the company is its deep-seated expertise within the pharmaceutical industry, where it provides critical support for product portfolios and direct mail campaigns while strictly complying with FDA guidelines. By integrating visual design, photography, and on-demand printing services, Newark Trade functions as a full-service partner for organizations requiring precision, reliability, and regulatory compliance in their marketing and informational materials.
How much funding has Newark Trade raised?
Newark Trade has raised a total of $363K across 2 funding rounds:
Debt
$150K
Debt
$213K
Debt (2020): $150K with participation from PPP
Debt (2021): $213K led by PPP
Key Investors in Newark Trade
PPP
Public-Private Partnership
What's next for Newark Trade?
With the recent infusion of $213K, Newark Trade is well-positioned to accelerate its strategic initiatives in the printing and creative services landscape. The company is expected to focus on enhancing its digital printing infrastructure and expanding its footprint within the highly regulated pharmaceutical sector. Future growth will likely be driven by investments in advanced automation and high-fidelity production technologies, allowing the firm to meet the increasing demand for on-demand, high-quality visual assets. As the company continues to scale, its ability to maintain stringent quality control while diversifying its service portfolio will be paramount to sustaining its competitive advantage in an evolving industrial market.
See full Newark Trade company page
